Nattokinase supplements come with numbers that can feel like a puzzle. The label says 2000 FU or 4000 FU, but the leap between them isn't just a dose doubled—it's a choice about what you're hoping to get from the enzyme. Understanding that difference starts with knowing what FU actually measures, and why the number on the bottle sometimes tells only part of the story.
At its core, FU stands for fibrinolytic units, a way to quantify the enzyme's ability to break down fibrin, a protein involved in blood clot formation. But as ConsumerLab.com found in a review of eight supplements, the lab-tested activity can diverge sharply from the label claim. Some products delivered far less than promised, and one packed nearly 60% more. So the dosage you think you're taking might not be the dosage your body sees.
What Is Nattokinase and How Is It Measured?
Nattokinase is an enzyme extracted from natto, a traditional Japanese food made from fermented soybeans. Its most studied trait is its fibrinolytic activity—the ability to break down fibrin, which is central to the body's blood-clotting process. Memorial Sloan Kettering Cancer Center notes that nattokinase can degrade fibrin directly and may also increase the body's own clot-dissolving pathways.
Fibrinolytic units (FU) quantify that activity. The measurement originated from early research on nattokinase, where one FU was defined by the enzyme's action on a fibrin plate under specific conditions. Most supplements list their potency in FU or milligrams, but the two aren't interchangeable. A product labeled 100 mg might contain 2,000 FU of activity, or far less—ConsumerLab testing revealed two supplements fell well below their labeled marks, with one delivering under 50% of its claim. Common strengths include 2,000 FU and 4,000 FU, but the actual enzyme activity you ingest depends on manufacturing quality and stability.
Comparing 2000 FU and 4000 FU: What the Evidence Shows
When you set a 2,000 FU capsule next to a 4,000 FU one, the obvious difference is the number. But the real question is whether that doubling produces a meaningfully different effect. The research doesn't provide a clean dose-response curve, and the products themselves vary in reliability. Some studies have used lower doses, others higher, and the outcomes they report don't necessarily scale with the FU count.
ConsumerLab's review highlighted that not all supplements deliver what they claim. One product labeled at 4,000 FU contained 82% of that amount, while a 2,000 FU product might deviate in either direction. So comparing two doses on paper assumes you're actually getting those doses—an assumption that testing sometimes undermines. The biological response also depends on individual factors like gut absorption and baseline fibrinogen levels, which no single dosage can account for.
What 2000 FU Typically Offers
A 2,000 FU dose often appears in studies looking at general cardiovascular endpoints. For instance, Kim et al. 2008 (Hypertens Res) gave participants 2,000 FU of nattokinase daily and reported a reduction in blood pressure over eight weeks. That trial used a relatively modest dose, and the outcome was a change in a risk factor, not a direct measure of clot prevention.
Products like Nutricost Nattokinase 2,000 FU sit at this level. ConsumerLab found that Nutricost's supplement was among those that passed testing for label accuracy, meaning the 2,000 FU on the bottle matched the enzyme activity in the lab. For someone new to nattokinase, a lower dose offers a starting point to gauge tolerance without jumping to the higher end of the typical range. It may be a practical entry point, especially if you're otherwise healthy and not on blood-thinning medications.
What 4000 FU Typically Offers
Higher doses appear in research focused on fibrinolytic effects. Sumi et al. 1990 (Acta Haematol) used 4,000 FU to demonstrate an increase in fibrinolytic activity in plasma after oral administration. The study's design was early-phase, and the finding was a biochemical marker change, not a clinical outcome. Still, the 4,000 FU figure became a common reference point.
Double Wood Supplements Nattokinase 4,000 FU is an example of this dosage. ConsumerLab's testing data on this specific product isn't detailed in the summary, but general patterns from the review show that higher-potency supplements can be either over- or under-powered. The 4,000 FU choice isn't a simple upgrade; it brings a different risk profile. WebMD warns that nattokinase may interact with anticoagulant and antiplatelet drugs, and that risk may increase with higher doses. The case reports aren't hypothetical—there's documentation of a cerebellar hemorrhage when nattokinase was combined with aspirin, and an elderly woman developed hemoperitoneum possibly linked to nattokinase use.
Safety and Interactions: What You Need to Know
The enzyme's ability to break down fibrin also means it can amplify the effects of blood-thinning medications. Both WebMD and the Memorial Sloan Kettering Cancer Center list interactions with anticoagulants like warfarin and antiplatelet drugs like aspirin. The mechanism isn't a minor overlap; nattokinase directly degrades fibrin and can alter clotting time, as shown by increases in PT, PTT, and INR in lab studies.
Severe events have been reported. One case involved a person who self-substituted nattokinase for warfarin and later required a repeat heart valve replacement. In another, the combination of nattokinase and aspirin was linked to a cerebellar hemorrhage. These aren't common occurrences, but they underscore that the enzyme isn't a gentle supplement for everyone. The variability in product quality adds another layer of unease: ConsumerLab's review found that 3 out of 8 supplements failed testing, with one providing nearly 60% more enzyme activity than stated. An over-potent capsule could deliver a dose far higher than intended, increasing the likelihood of side effects.
There's also a risk specific to natto allergy, and caution is warranted for anyone with a known sensitivity to soy. The lack of clinical evidence for many conditions—like cancer or atherosclerosis—means the risks aren't always balanced by proven benefits. The null effect on atherosclerosis in healthy individuals, noted in one study, suggests that the enzyme's impact on already-formed plaques is not a given.
Choosing Between 2000 FU and 4000 FU
If you're standing in the supplement aisle trying to decide between these two strengths, the answer isn't on the bottle. It's in a conversation with a healthcare provider who knows your medication list and health history. For someone not on blood thinners and with a lower risk of bleeding, starting with 2,000 FU may be a reasonable way to assess tolerance. For individuals with a specific fibrinolytic need under medical supervision, 4,000 FU might be considered, but the decision should be guided by more than the label claim.
Product quality matters at least as much as the stated dose. ConsumerLab's finding that price ranged from $0.10 to $1.17 per same amount of enzyme activity—and that a higher price didn't guarantee a better product—means you can't simply spend your way to reliability. Look for third-party testing that verifies label accuracy. Some supplements, like the Nattokinase 18-in-1 Potent Blend, combine multiple enzymes and ingredients, which adds complexity; the same principles apply. The goal is to know what you're actually taking, not just what the label says.
Frequently Asked Questions
Can I take 4000 FU if I’m new to nattokinase?
Starting with a lower dose, such as 2,000 FU, is often recommended to see how your body responds. Many studies used 2,000 FU, and a 4,000 FU starting point may increase the risk of interactions, especially if you take other medications.
What does the research say about dosing?
Trials have used a range from 2,000 FU to 4,000 FU daily, but no single dose is established as optimal. The outcomes are tied to specific study designs—blood pressure in one, fibrinolytic activity in another—and don't translate to a universal recommendation.
Is there a risk of overdose with nattokinase?
There's no clearly defined overdose threshold, but higher doses can elevate bleeding risk. The potential for an over-potent supplement—one providing more enzyme activity than labeled—makes label accuracy critical, as shown by ConsumerLab's testing.